CEFUROXIME (CEFUROXIME SODIUM) — all Canadian products
16 DINs
2 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is CEFUROXIME (CEFUROXIME SODIUM), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02241639 | CEFUROXIME FOR INJECTION, USP | FRESENIUS KABI CANADA LTD | Powder For Solution | Intravenous | CEFUROXIME (CEFUROXIME SODIUM) 1.5 G | Marketed | |
| 02241638 | CEFUROXIME FOR INJECTION, USP | FRESENIUS KABI CANADA LTD | Powder For Solution | Intravenous | CEFUROXIME (CEFUROXIME SODIUM) 750 MG | Marketed | |
| 02237731 | CEFUROXIME FOR INJECTION USP | PHARMACEUTICAL PARTNERS OF CANADA INC | Powder For Solution | Intramuscular; Intravenous | CEFUROXIME (CEFUROXIME SODIUM) 750 MG | Cancelled Post Market | |
| 02237733 | CEFUROXIME FOR INJECTION USP | PHARMACEUTICAL PARTNERS OF CANADA INC | Powder For Solution | Intravenous | CEFUROXIME (CEFUROXIME SODIUM) 7.5 G | Cancelled Post Market | |
| 02237732 | CEFUROXIME FOR INJECTION USP | PHARMACEUTICAL PARTNERS OF CANADA INC | Powder For Solution | Intravenous | CEFUROXIME (CEFUROXIME SODIUM) 1.5 G | Cancelled Post Market | |
| 02422328 | CEFUROXIME FOR INJECTION, USP | HIKMA CANADA LIMITED | Powder For Solution | Intravenous | CEFUROXIME (CEFUROXIME SODIUM) 7.5 G | Dormant | |
| 02241640 | CEFUROXIME FOR INJECTION, USP | FRESENIUS KABI CANADA LTD | Powder For Solution | Intravenous | CEFUROXIME (CEFUROXIME SODIUM) 7.5 G | Cancelled Post Market | |
| 02422298 | CEFUROXIME FOR INJECTION, USP | HIKMA CANADA LIMITED | Powder For Solution | Intravenous | CEFUROXIME (CEFUROXIME SODIUM) 750 MG | Dormant | |
| 02422301 | CEFUROXIME FOR INJECTION, USP | HIKMA CANADA LIMITED | Powder For Solution | Intravenous | CEFUROXIME (CEFUROXIME SODIUM) 1.5 G | Dormant | |
| 01986082 | KEFUROX | PHARMACEUTICAL PARTNERS OF CANADA INC | Powder For Solution | Intravenous | CEFUROXIME (CEFUROXIME SODIUM) 7.5 G | Cancelled Post Market | |
| 01927264 | KEFUROX | PHARMACEUTICAL PARTNERS OF CANADA INC | Powder For Solution | Intravenous | CEFUROXIME (CEFUROXIME SODIUM) 1.5 G | Cancelled Post Market | |
| 01927256 | KEFUROX | PHARMACEUTICAL PARTNERS OF CANADA INC | Powder For Solution | Intravenous | CEFUROXIME (CEFUROXIME SODIUM) 750 MG | Cancelled Post Market | |
| 01935828 | KEFUROX INJ PWS 750MG/ADD-VANTAGE VIAL | ELI LILLY CANADA INC | Powder For Solution | Intravenous | CEFUROXIME (CEFUROXIME SODIUM) 750 MG | Cancelled Post Market | |
| 00481890 | ZINACEF INJ 1.5GM/VIAL | GLAXO CANADA INC | Powder For Solution | Intravenous; Intramuscular | CEFUROXIME (CEFUROXIME SODIUM) 1.5 G | Cancelled Post Market | |
| 00890936 | ZINACEF INJ 7.5GM/VIAL | GLAXO CANADA INC | Powder For Solution | Intravenous | CEFUROXIME (CEFUROXIME SODIUM) 7.5 G | Cancelled Post Market | |
| 00497843 | ZINACEF INJ 750MG/VIAL | GLAXO CANADA INC | Powder For Solution | Intravenous; Intramuscular | CEFUROXIME (CEFUROXIME SODIUM) 750 MG | Cancelled Post Market |
Browse other molecules: